Paper20135207
Model analysis of the concentration-dependent permeability of P-gp substrates.
Tachibana T and 6 others. Pharm Res, 2010. Cited by 86 papers, by iCite.
Cite this record
ConductScience Library. Model analysis of the concentration-dependent permeability of P-gp substrates. Papers, record 20135207. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20135207
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | Major topic |
| Quinidine | Major topic |
| Verapamil | Major topic |
| Vinblastine | Major topic |
| Animals | |
| Biological Transport | |
| Caco-2 Cells | |
| Gene Expression | |
| Humans | |
| Models, Biological |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12047481 | Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL. | Br J Clin Pharmacol | 2002 | https://conductscience.org/library/papers/12047481 | PubMed |
| 2 | 12134945 | Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa? | Pharm Res | 2002 | https://conductscience.org/library/papers/12134945 | PubMed |
| 3 | 18276834 | Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo. | Drug Metab Dispos | 2008 | https://conductscience.org/library/papers/18276834 | PubMed |
| 4 | 12608532 | Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031. | Pharm Res | 2003 | https://conductscience.org/library/papers/12608532 | PubMed |
| 5 | 8710739 | Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo. | Pharm Res | 1996 | https://conductscience.org/library/papers/8710739 | PubMed |
| 6 | 10706193 | P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. | Int J Clin Pharmacol Ther | 2000 | https://conductscience.org/library/papers/10706193 | PubMed |
| 7 | 12869659 | Impact of drug transporter studies on drug discovery and development. | Pharmacol Rev | 2003 | https://conductscience.org/library/papers/12869659 | PubMed |
| 8 | 11990778 | Functional polymorphisms of the human multidrug resistance (MDR1) gene: correlation with P glycoprotein expression and activity in vivo. | Novartis Found Symp | 2002 | https://conductscience.org/library/papers/11990778 | PubMed |
| 9 | 2864056 | Celiprolol: pharmacokinetics and duration of pharmacodynamic activity. | Br J Clin Pract Suppl | 1985 | https://conductscience.org/library/papers/2864056 | PubMed |
| 10 | 11327196 | The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. | Clin Pharmacokinet | 2001 | https://conductscience.org/library/papers/11327196 | PubMed |
| 11 | 15276711 | Importance of P-glycoprotein at blood-tissue barriers. | Trends Pharmacol Sci | 2004 | https://conductscience.org/library/papers/15276711 | PubMed |
| 12 | 17828734 | Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane. | J Pharm Sci | 2008 | https://conductscience.org/library/papers/17828734 | PubMed |
| 13 | 17548462 | Decrease in intracellular concentration causes the shift in Km value of efflux pump substrates. | Drug Metab Dispos | 2007 | https://conductscience.org/library/papers/17548462 | PubMed |
| 14 | 14641550 | Importance of P-glycoprotein for drug disposition in humans. | Eur J Clin Invest | 2003 | https://conductscience.org/library/papers/14641550 | PubMed |
| 15 | 1979923 | Pharmacokinetics of pafenolol after i.v. and oral administration of three separate doses of different strength to man. | Biopharm Drug Dispos | 1990 | https://conductscience.org/library/papers/1979923 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41735693 | Quantitative Analysis of the Effect of Gastrointestinal Water Dynamics on Oral Drug Absorption using a Physiologically Based Integrated Liquid and Intestinal Absorption Drug (ILIAD) Pharmacokinetic Model. | Pharm Res | 2026 | https://conductscience.org/library/papers/41735693 | PubMed |
| 41731530 | Evaluating sex as a biological variable in in vitro blood-brain barrier models: insights from primary mouse brain endothelial cells. | Fluids Barriers CNS | 2026 | https://conductscience.org/library/papers/41731530 | PubMed |
| 41629699 | Simulation-based assessment of the P-glycoprotein expression-activity relationship shows a drug and system dependency. | J Pharmacokinet Pharmacodyn | 2026 | https://conductscience.org/library/papers/41629699 | PubMed |
| 41304794 | Classifying Effluxable Versus Non-Effluxable Compounds Using a Permeability Threshold Based on Fundamental Energy Constraints. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41304794 | PubMed |
| 39921770 | Reliability of in vitro data for the mechanistic prediction of brain extracellular fluid pharmacokinetics of P-glycoprotein substrates in vivo; are we scaling correctly? | J Pharmacokinet Pharmacodyn | 2025 | https://conductscience.org/library/papers/39921770 | PubMed |
| 39838673 | Network Pharmacology, Molecular Docking, Molecular Dynamics to Explore the Mechanism of Danggui Shaoyao Powder for Hepatic Encephalopathy. | Curr Pharm Des | 2025 | https://conductscience.org/library/papers/39838673 | PubMed |
| 39542928 | Drug-induced cholestasis (DIC) predictions based on in vitro inhibition of major bile acid clearance mechanisms. | Arch Toxicol | 2025 | https://conductscience.org/library/papers/39542928 | PubMed |
| 37283406 | Interlaboratory Variability in the Madin-Darby Canine Kidney Cell Proteome. | Mol Pharm | 2023 | https://conductscience.org/library/papers/37283406 | PubMed |
| 37101392 | Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug-drug-disease interactions: M4 contribution. | CPT Pharmacometrics Syst Pharmacol | 2023 | https://conductscience.org/library/papers/37101392 | PubMed |
| 36541850 | The Rat Continuous Intestine Model Predicts the Impact of Particle Size and Transporters on the Oral Absorption of Glyburide. | Mol Pharm | 2023 | https://conductscience.org/library/papers/36541850 | PubMed |
| 35501528 | A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development. | AAPS J | 2022 | https://conductscience.org/library/papers/35501528 | PubMed |
| 35488144 | Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in Dogs. | Pharm Res | 2022 | https://conductscience.org/library/papers/35488144 | PubMed |
| 35083640 | Limited Impact of Murine Placental MDR1 on Fetal Exposure of Certain Drugs Explained by Bypass Transfer Between Adjacent Syncytiotrophoblast Layers. | Pharm Res | 2022 | https://conductscience.org/library/papers/35083640 | PubMed |
| 34729944 | Unraveling pleiotropic effects of rifampicin by using physiologically based pharmacokinetic modeling: Assessing the induction magnitude of P-glycoprotein-cytochrome P450 3A4 dual substrates. | CPT Pharmacometrics Syst Pharmacol | 2021 | https://conductscience.org/library/papers/34729944 | PubMed |
| 34668334 | Physiologically-based pharmacokinetic modeling to evaluate in vitro-to-in vivo extrapolation for intestinal P-glycoprotein inhibition. | CPT Pharmacometrics Syst Pharmacol | 2022 | https://conductscience.org/library/papers/34668334 | PubMed |
| 34272714 | Case Study 7: Transporters Case Studies-In Vitro Solutions for Translatable Outcomes. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/34272714 | PubMed |
| 34272702 | Prediction of Drug Clearance from Enzyme and Transporter Kinetics. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/34272702 | PubMed |
| 34272693 | Consideration of the Unbound Drug Concentration in Enzyme Kinetics. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/34272693 | PubMed |
| 34080309 | Model-based assessments of CYP3A-mediated drug-drug interaction risk of milademetan. | Clin Transl Sci | 2021 | https://conductscience.org/library/papers/34080309 | PubMed |
| 34009624 | Analysis of Non-linear Pharmacokinetics of P-Glycoprotein Substrates in a Microfluidic Device Using a Mathematical Model that Includes an Unstirred Water Layer (UWL) Compartment. | Pharm Res | 2021 | https://conductscience.org/library/papers/34009624 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20135207
GET https://conductscience.org/api/papers/v1/20135207/cited_by?page=2